Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
Krystal Biotech 宣佈在用於治療局部晚期或轉移性肺部實體瘤的吸入 KB707 臨床試驗中,首位患者服用劑量
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
Krystal Biotech 宣佈在用於治療局部晚期或轉移性肺部實體瘤的吸入 KB707 臨床試驗中,首位患者服用劑量
使用瀏覽器的分享功能,分享給你的好友吧